Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Puma Biotechnology Inc (PBYI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Puma Biotech's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5.170 +0.070    +1.37%
17/04 - Closed. Currency in USD ( Disclaimer )
After Hours
5.030
-0.140
-2.708%
16:51:47 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 247,084
  • Bid/Ask: 4.800 / 5.180
  • Day's Range: 5.050 - 5.300
Puma Biotech 5.170 +0.070 +1.37%

PBYI Balance Sheet

 
Featured here, the Balance Sheet for Puma Biotechnology Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 156.18 125.35 118.55 111.75
Cash and Short Term Investments 95.94 85.03 74.44 71.22
Cash - - - -
Cash & Equivalents 84.58 81.8 60.01 61.39
Short Term Investments 11.35 3.23 14.43 9.82
Total Receivables, Net 48.49 28.97 31.29 31.16
Accounts Receivables - Trade, Net 47.84 28.97 31.29 31.16
Total Inventory 7.08 5.68 7.63 3.89
Prepaid Expenses 2.48 1.43 2.19 5.03
Other Current Assets, Total 2.19 4.24 3 0.449
Total Assets 230.53 203.6 200.49 196.26
Property/Plant/Equipment, Total - Net 8.65 9.45 10.89 11.67
Property/Plant/Equipment, Total - Gross 16.33 17.21 18.55 19.22
Accumulated Depreciation, Total -7.68 -7.76 -7.66 -7.55
Goodwill, Net - - - -
Intangibles, Net 60.87 63.3 65.74 68.18
Long Term Investments - - - -
Note Receivable - Long Term 0.652 - - -
Other Long Term Assets, Total 4.62 5.33 5.14 4.63
Other Assets, Total -27.65 -15.66 -6.06 -16.97
Total Current Liabilities 99.38 67.36 60.29 48.19
Accounts Payable 6.89 5.06 7.8 8.59
Payable/Accrued - - - -
Accrued Expenses 35.63 24.74 22.24 21.5
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 38.8 27.29 15.79 4.3
Other Current liabilities, Total 18.07 10.27 14.46 13.8
Total Liabilities 177.09 164.86 170.1 170.41
Total Long Term Debt 65.66 76.63 87.62 98.62
Long Term Debt 65.66 76.63 87.62 98.62
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 12.04 20.87 22.19 23.6
Total Equity 53.44 38.74 30.4 25.85
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.005 0.005 0.005 0.005
Additional Paid-In Capital 1398.6 1396.17 1393.63 1391.2
Retained Earnings (Accumulated Deficit) -1345.16 -1357.43 -1363.23 -1365.35
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -0.004 -0.004 -0.006 -
Total Liabilities & Shareholders' Equity 230.53 203.6 200.49 196.26
Total Common Shares Outstanding 47.65 47.54 46.95 46.66
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PBYI Comments

Write your thoughts about Puma Biotechnology Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Mahony
Mike Mahony Dec 23, 2022 4:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bad Article from financial advisor on seeking alpha...that the ones who let fill stop loss hunting orders
Seller Beware
Seller Beware Dec 13, 2021 2:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just look at this stpd chart. How crazy rich are these Puma Sellers. They only laugh at poor Puma
Seller Beware
Seller Beware Dec 13, 2021 2:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pump* Biotech
Jimmy Barjami
Jimmy Barjami Nov 17, 2021 7:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What’s going on with this toxic stock
Episcopolian OptionTrader
Episcopolian1 May 07, 2020 4:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Puma Biotechnology Q1 Adj. EPS $(0.200) Beats $(0.730) Estimate, Sales $48.600M Beat $47.060M Estimate
Peter Wiedeking
Peter Wiedeking Feb 05, 2020 1:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
14,5 short
Anthony Santos
Anthony Santos Nov 06, 2019 9:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
today will be earnings as All eyes will be on the Useless CEO
Episcopolian OptionTrader
Episcopolian1 Jul 12, 2017 10:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Leerink set PT to $115. Wonder if they think there is no immediate buyer?
Episcopolian OptionTrader
Episcopolian1 May 23, 2017 8:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$PBYI will be presenting at ASCO on 6/3/17. Buy the stock now... This can go above $100 easily before the event
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email